ZYUS Stock Overview
ZYUS Life Sciences Corporation manufactures and distributes phyto-therapeutic compounds and cannabis-based medicines in Canada and internationally.
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 2/6 |
| Past Performance | 0/6 |
| Financial Health | 4/6 |
| Dividends | 0/6 |
ZYUS Life Sciences Corporation Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CA$1.01 |
| 52 Week High | CA$1.41 |
| 52 Week Low | CA$0.71 |
| Beta | 0 |
| 1 Month Change | -3.81% |
| 3 Month Change | 9.78% |
| 1 Year Change | n/a |
| 3 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | -12.17% |
Recent News & Updates
Recent updates
Shareholder Returns
| ZYUS | CA Pharmaceuticals | CA Market | |
|---|---|---|---|
| 7D | 1.0% | -6.6% | 0.7% |
| 1Y | n/a | 41.0% | 4.9% |
Return vs Industry: Insufficient data to determine how ZYUS performed against the Canadian Pharmaceuticals industry.
Return vs Market: Insufficient data to determine how ZYUS performed against the Canadian Market.
Price Volatility
| ZYUS volatility | |
|---|---|
| ZYUS Average Weekly Movement | 5.1% |
| Pharmaceuticals Industry Average Movement | 13.8% |
| Market Average Movement | 9.0% |
| 10% most volatile stocks in CA Market | 18.1% |
| 10% least volatile stocks in CA Market | 3.0% |
Stable Share Price: ZYUS has not had significant price volatility in the past 3 months.
Volatility Over Time: ZYUS's weekly volatility (5%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1944 | n/a | Brent Zettl | www.zyus.com |
ZYUS Life Sciences Corporation manufactures and distributes phyto-therapeutic compounds and cannabis-based medicines in Canada and internationally. The company offers cannabinoid-based therapeutics and products, such as oils, gel-caps, and topical creams. ZYUS Life Sciences Corporation was incorporated in 1944 and is based in Saskatoon, Canada.
ZYUS Life Sciences Corporation Fundamentals Summary
| ZYUS fundamental statistics | |
|---|---|
| Market cap | CA$71.56m |
| Earnings (TTM) | -CA$24.10m |
| Revenue (TTM) | CA$329.00k |
217.5x
P/S Ratio-3.0x
P/E RatioIs ZYUS overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| ZYUS income statement (TTM) | |
|---|---|
| Revenue | CA$329.00k |
| Cost of Revenue | CA$251.00k |
| Gross Profit | CA$78.00k |
| Other Expenses | CA$24.18m |
| Earnings | -CA$24.10m |
Last Reported Earnings
Sep 30, 2023
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.34 |
| Gross Margin | 23.71% |
| Net Profit Margin | -7,325.23% |
| Debt/Equity Ratio | 16.8% |
How did ZYUS perform over the long term?
See historical performance and comparison